Epidemiology of Bloodstream Infections at a Cancer Center
Keywords:
Bloodstream infection, Cancer, Epidemiology, MicrobiologyAbstract
CONTEXT: Cancer patients are at unusually high risk for developing bloodstream infections (BSI), which are a major cause of in-hospital morbidity and mortality. OBJECTIVE: To describe the epidemiological characteristics and the etiology of BSI in cancer patients. DESIGN: Descriptive study. SETTING: Terciary Oncology Care Center. PARTICIPANTS: During a 24-month period all hospitalized patients with clinically significant BSI were evaluated in relation to several clinical and demographic factors. RESULTS: The study enrolled 435 episodes of BSI (349 patients). The majority of the episodes occurred among non-neutropenic patients (58.6%) and in those younger than 40 years (58.2%). There was a higher occurrence of unimicrobial infections (74.9%), nosocomial episodes (68.3%) and of those of undetermined origin (52.8%). Central venous catheters (CVC) were present in 63.2% of the episodes. Overall, the commonest isolates from blood in patients with hematology diseases and solid tumors were staphylococci (32% and 34.7%, respectively). There were 70 episodes of fungemia with a predominance of Candida albicans organisms (50.6%). Fungi were identified in 52.5% of persistent BSI and in 91.4% of patients with CVC. Gram-negative bacilli prompted the CVC removal in 45.5% of the episodes. Oxacillin resistance was detected in 26.3% of Staphylococcus aureus isolates and in 61.8% of coagulase-negative Staphylococcus. Vancomycin-resistant enterococci were not observed. Initial empirical antimicrobial therapy was considered appropriate in 60.5% of the cases. CONCLUSION: The identification of the microbiology profile of BSI and the recognition of possible risk factors in high-risk cancer patients may help in planning and conducting more effective infection control and preventive measures, and may also allow further analytical studies for reducing severe infectious complications in such groups of patients.
Downloads
References
Koll BS, Brown AE. The changing epidemiology of infections at cancer hospitals. Clin Infect Dis 1993;17(Suppl):S322-8.
Nucci M, Silveira MI, Velasco E, et al. Risk factors for death among cancer patients with fungemia. Clin Infect Dis 1998;27(1):107-11.
Gonzalez-Barca E, Fernandez-Sevilla A, Carratala J, Gudiol F. Prospective study of 288 episodes of bacteremia in neutropenic cancer patients in a single institution. Eur J Clin Microbiol Infect Dis 1996;15(4):291-6.
Karnofsky DA, Burchenot JH. The clinical evaluation of chemotherapeutic agents in cancer. In: MacLead CM, editor. Evaluation of chemotherapeutic agents. New York: New York Columbia Univ. Press, 1949:191-205.
Fauci AS, Dale DC, Below JE. Glucocorticosteroid therapy: mechanisms of action and clinical considerations [NIH conference]. Ann Intern Med 1976,84:304-15.
Sickles E, Greene W, Wiernik PH. Clinical presentation of infection in granulocytopenic patients. Arch Intern Med 1975,135:715-9.
Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections, 1988. Am J Infect Contr 1988,16:128-40.
National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. 2nd ed. Approved standard. NCCLS document M7-A2. Villanova, Pennsylvania: National Committee for Clinical Laboratory Standards; 1990.
Weinstein MP, Towns ML, Quartey SM, et al. The clinical significance of positive blood cultures in the 1990s: a prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungemia in adults. Clin Infect Dis 1997;24:584-602.
Geerdes HF, Ziegler D, Lode H, et al. Septicemia in 980 patients at a university hospital in Berlin: prospective studies during 4 selected years between 1979 and 1989. Clin Infect Dis 1992;15:991-1002.
Carlisle PS, Gucalp R, Wiernik P. Nosocomial infections in neutropenic cancer patients. Infect Control Hosp Epidemiol 1993;14:320-24.
Weinstein MP, Murphy JR, Reller LB, Lichtenstein KA. The clinical significance of positive blood culture: a comprehensive analysis of 500 episodes of bacteremia and fungemia in adults. II. Clinical observations, with special references to factors influencing prognosis. Rev Infect Dis 1983;5:54-70.
McGowan JE Jr, Barnes MW, Finland M. Bacteremia at Boston City Hospital: occurrence and mortality during 12 selected years (1935-1972), with special references to hospital-acquired cases. J Infect Dis 1975;32:316-35.
Roberts FJ, Geere IW, Coldman A. Three-year study of positive blood cultures, with emphasis on prognosis. Rev Infect Dis 1991;13:34-46.
Emori TG, Banerjee SN, Culver DH, et al. Nosocomial infections in elderly patients in the United States, 1986-90. National Nosocomial Infections Surveillance System. Am J Med 1991;91: 289S-93S.
Pittet D, Li N, Woolson RF, Wenzel R. Microbiological factors influencing the outcome of nosocomial bloodstream infections: a 6-year validated, population-based model. Clin Infect Dis 1997;24:1068-78.
Elting LS, Bodey GP. Septicemia due to Xanthomonas species and non-aeruginosa Pseudomonas species: increasing incidence of catheter-related infections. Medicine 1990;69:296-306.
Sherertz RJ. Practical healthcare epidemiology: surveillance for infections associated with vascular catheters. Infect Contr Hosp Epidemiol 1996;17:746-52.
Raad I, Narro J, Khan A, Tarrand J, Vartivarian S, Bodey GP. Serious complications of vascular catheter-related Staphylococcus aureus bacteremia in cancer patients. Eur J Clin Microbiol Infect Dis 1992;11(8):675-82.
Bates DW, Goldman L, Lee TH. Contaminant blood cultures and resource utilization: the true consequences of false-positive results. JAMA 1991;265:365-9.
Desjardin JA, Falagas ME, Ruthazer R, et al. Clinical utility of blood cultures drawn from indwelling central venous catheters in hospitalized patients with cancer. Ann Intern Med 1999;131:641-47.
Wormser GP, Onorato IM, Preminger TJ, Culver D, Martone WJ. Sensitivity and specificity of blood cultures obtained through intravascular catheters. Crit Care Med 1990;18:152-56.
Elting LS, Bodey GP, Feinstein V. Polymicrobial septicemia in the cancer patient. Medicine 1986;65:218-25.
Cooper GS, Havlir DS, Shlales DM, Salata RA. Polymicrobial bacteremia in the late 1980's: predictors of outcome and review of the literature. Medicine 1990;69:114-23.
